BOARD OF DIRECTORS

James Huang

Chairman

James Huang brings over 30 years of experience in the healthcare industry across Asia and the US as a member of ANIVIA Medical’s board of directors since 2018. He is the Founding Managing Partner of Panacea Venture, where he leads investments in life science companies. Prior to founding Panacea, James held Managing Partner roles at Kleiner Perkins and Vivo Ventures, as well as senior positions at leading healthcare companies such as Tularik, GlaxoSmithKline, Bristol-Meyers Squibb, and ALZA Corp. James has a proven track record of success in business development, marketing, and R&D functions. He holds an M.B.A. from Stanford Graduate School of Business and a B.S. degree in chemical engineering from the University of California, Berkeley.

Henry Lin, Ph.D.

Founder & CEO

Dr. Henry Lin is a co-founder and CEO of ANIVIA Medical, With a background in innovative medical technology. He brings extensive knowledge and expertise to the company. He has successfully executed multiple first-in-human clinical studies globally, showcasing his ability to effectively bridge the gap between technical and medical teams. Throughout his career, Dr. Lin has demonstrated a proven track record of securing multi-million-dollar investments from reputable institutional investors. He holds a Ph.D. in Medicine from the University of Queensland, Australia and a Master’s degree in Biotechnology. In addition, he has completed a postdoctoral fellowship at Massachusetts General Hospital and Harvard Medical School and holds an A.L.M. in Management from Harvard University, where he was honored with a distinguished academic achievement award.

Alex Lu

Director

Alex Lu stands as one of the initial individual investors in ANIVIA Medical, showcasing extensive investment and operational expertise spanning medical technology, real estate, and high-tech sectors across the Pacific. Currently holding the position of Board Director at Keetai Properties Co., Ltd. (TWSE: 2538), Alex’s professional journey includes co-founding and leading business development at Splashtop Inc. in California, a prominent provider of remote management solutions. Preceding his role at Splashtop Inc., he held various business development positions at Applied Materials Inc., a global leader in semiconductor equipment provision. Alex holds an MBA from Drexel University in Philadelphia and a BS in Chemical Engineering from Tunghai University in Taiwan.

MANAGEMENT TEAM

Henry Lin, Ph.D.

Founder & CEO

Dr. Henry Lin is a co-founder and CEO of ANIVIA Medical. With a background in innovative medical technology, he brings extensive knowledge and expertise to the company. He has successfully executed multiple first-in-human clinical studies globally, showcasing his ability to effectively bridge the gap between technical and medical teams. Throughout his career, Dr. Lin has demonstrated a proven track record of securing multi-million-dollar investments from reputable institutional investors. He holds a Ph.D. in Medicine from the University of Queensland, Australia and a Master’s degree in Biotechnology. In addition, he has completed a postdoctoral fellowship at Massachusetts General Hospital and Harvard Medical School and holds an A.L.M. in Management from Harvard University, where he was honored with a distinguished academic achievement award.

John Gilbert, Ph.D.

Chief Technology Officer

Dr. John Gilbert is a co-founder and Chief Technology Officer of ANIVIA Medical, where he also serves on the Board of Directors. With over 50 issued U.S. patents and extensive experience as both a founding CEO and CTO, Dr. Gilbert is a specialist in start-up operations, technology assessment, regulation, IP creation, and business model development in the medical technology industry. He played a pivotal role in inventing ANIVIA Medical‘s extracorporeal platform technology and establishing the company’s intellectual property portfolio. Dr. Gilbert holds an A.B. and M.A. from Harvard University, a Ph.D. in physics from the California Institute of Technology, and completed a postdoctoral fellowship at the Massachusetts Institute of Technology.

Leroy Yau

Chief Financial Officer

Experienced finance and risk management leader with 25+ years spanning venture capital, corporate governance, and strategic advisory. Former EY and KPMG partner with expertise in enterprise risk, M&A, and regulatory compliance. Deep experience in scaling early-stage ventures and managing financial strategy across global markets.

John Sasso

General Manager

Seasoned medtech leader with 25+ years of experience, including roles at Haemonetics, Radi Medical (now Abbott), and MITRE. Expertise in operations, commercialization, and regulatory affairs, with a proven track record in strategy and execution.

Heather Keith

Head of Product Commercialization

Seasoned commercial leader with 15+ years in sales, marketing, and operations, driving revenue growth and product launches across medtech and life sciences. Held leadership roles at Battelle, TEI BioSciences, and neuroClues, with expertise in sales strategy, team management, IP licensing, and go-to-market execution.

Thomas Shannon

Marketing

Global marketing and business development executive with 30+ years in cardiovascular and cardiopulmonary sectors. Led commercialization, brand strategy, and product launches at Medtronic, Getinge, and Fresenius Medical Care. Former clinical perfusionist with expertise in ECLS, ECMO, and disruptive medtech commercialization.

Julia Yuan

Regulatory & Clinical Affairs

Regulatory and clinical expert with 25+ years in the pharmaceutical and medtech industries. Led clinical operations and regulatory strategy at IQVIA, Boston Scientific, and AstraZeneca. Deep expertise in clinical trials, quality systems, and global regulatory pathways, with a strong focus on bringing innovative medical technologies to market.

RESEARCH AND DEVELOPMENT

John Gilbert, Ph.D.

Chief Technology Officer

Lim Cheung, Ph.D.

Senior Vice President of Engineering

Dr. Lim Cheung has 20+ years’ experience in medical device development in radiology and minimally invasive surgeries. He oversaw every stage from concept, R&D, engineering, manufacturing, quality, regulatory affairs, clinical trials to business operations at both large multinationals and small ventures. In previous roles as head of R&D, patent inventor, and chief designer at Hologic and Smith & Nephew in Boston, Dr. Cheung led teams that developed products generating billions of dollars in cumulative revenue and profit. He has a B.S. in Electrical Engineering from the California Institute of Technology and a Ph.D. in Physics from the University of Maryland. He held research positions at NASA and Harvard University.

John Sasso

General Manager

John is a skilled professional responsible for day-to-day project management of product development, manufacturing operations, and quality activities, as well as serving as the Management Representative and Person Responsible for Regulatory Compliance (PRRC). With previous experience at Radi Medical Systems, Haemonetics, Neoventa Medical, Strohl Medical Technologies, and Q-Urology, John has a successful track record of integrating project management methodologies and commercializing medical devices from both domestic and foreign manufacturers. John is also experienced in international business and has brought two foreign medical device companies into the United States, one of which grew to $28M in annual revenues. John received his B.S.E.E. and M.S.E.E. from Tufts University and his M.B.A from Bentley College, graduating as the Class Valedictorian.

Swee Ng

Senior Director of Engineering

Experienced medtech engineering leader with 15+ years in product development, manufacturing transfer, and commercialization. Led strategic initiatives at Cook Medical, driving new product development, supplier qualification, and global regulatory compliance. Expertise in R&D, quality systems, and scaling manufacturing operations.

For more information, please contact us.